|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 School of Biochemistry and Microbiology, The University of Leeds, Leeds, W. Yorks, United Kingdom
2 General Surgery, Medicine and Anaesthesia, School of Medicine, The University of Leeds, Leeds, W. Yorks, United Kingdom
3 Department of Clinical Studies, University of Pennsylvania school of Veterinary Medicine, Philadelphia, Pennsylvania, USA
* To whom correspondence should be addressed. E-mail: S.R.Carding{at}Leeds.ac.uk.
The interleukin-2 (IL-2)-deficient (IL-2-/-) mouse model of ulcerative colitis was used to test
the hypothesis that colonic epithelial cells (CEC) directly respond to bacterial antigens and
that alterations in Toll-like receptor- (TLR) mediated signaling may occur during the
development of colitis. TLR expression and activation of TLR-mediated signaling pathways
in primary CEC of healthy animals was compared with CEC in IL2-/- mice during the
development of colitis. In healthy animals, CEC expressed functional TLR and in response
to the TLR4 ligand, lipopolysaccharide (LPS), proliferated and secreted the cytokines, IL-6
and MCP-1. However, the TLR-responsiveness of CEC in IL-2-/- mice was different with
decreased TLR4 responsiveness and augmented TLR2 responses that result in IL-6 and
MCP-1 secretion. TLR signaling in CEC did not involve NF-
B (p65) activation with the
inhibitory p50 form of NF-
B predominating in CEC in both the healthy and inflamed colon.
The development of colitis was however associated with the activation of MAPK family
members and upregulation of MyD88-independent signaling pathways characterized by
increased caspase-1 activity and IL-18 production. These findings identify changes in TLR
expression and signaling during the development of colitis that may contribute to changes in
the host response to bacterial antigens seen in colitis.
This article has been cited by other articles:
![]() |
R. Ungaro, M. Fukata, D. Hsu, Y. Hernandez, K. Breglio, A. Chen, R. Xu, J. Sotolongo, C. Espana, J. Zaias, et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1167 - G1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Cruickshank, M. L. Deschoolmeester, M. Svensson, G. Howell, A. Bazakou, L. Logunova, M. C. Little, N. English, M. Mack, R. K. Grencis, et al. Rapid Dendritic Cell Mobilization to the Large Intestinal Epithelium Is Associated with Resistance to Trichuris muris Infection J. Immunol., March 1, 2009; 182(5): 3055 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Cario BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2 Gut, August 1, 2005; 54(8): 1182 - 1193. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |